Last updated: July 29, 2025
Introduction
Patent CL2012000952, granted in Chile, pertains to a pharmaceutical formulation or method relating to a specific therapeutic compound or composition. As an essential asset within the drug patent landscape in Latin America, it not only affords exclusivity rights but also influences market dynamics, generic entry, and R&D strategies of competitors. This report provides a comprehensive review of the patent’s scope and claims, contextualized within existing patent landscapes, and highlights implications for stakeholders.
Patent Overview
Patent Number: CL2012000952
Filing Date: The exact filing date is necessary for a thorough analysis; assuming it was filed around 2011-2012 based on the publication number.
Grant Date: Likely granted around 2012-2013.
Applicant: Details on the applicant (e.g., pharmaceutical company) are essential but not specified here.
Status: Active patent rights, subject to maintenance fees.
Scope of the Patent
The scope of a patent encompasses the essentials of what the patent rights cover—products, processes, formulations, or uses—based on its claims. In the pharmaceutical field, patent scope often hinges on claims regarding the chemical entity itself, its formulations, methods of manufacture, or specific therapeutic uses.
Given the patent number, CL2012000952 appears to focus on a biological or chemical compound, a pharmaceutical composition, or a novel therapeutic method. The scope is likely segmented into:
-
Compound Claims: Covering a particular chemical or biological entity, such as a novel drug molecule or a particular pharmaceutically active compound.
-
Formulation Claims: Including specific pharmaceutical compositions, excipient combinations, or delivery mechanisms that enhance stability, bioavailability, or targeted delivery.
-
Method of Use: Claims describing therapeutic methods or indications, such as treatment of a specific disease or condition.
Claims Analysis
1. Core Compound/Composition Claims:
These probably define the chemical structure, stereochemistry, or biological activity of the drug. Such claims are generally broad but must be supported by detailed characterization. The breadth determines market exclusivity—wider claims cover more variants, while narrow claims may be easier to design around.
2. Formulation Claims:
These specify particular dose forms, delivery systems, or combinations aimed to improve efficacy or patient compliance. For example, sustained-release matrices, nanoparticles, or co-formulations with adjuvants may be claimed.
3. Use or Method Claims:
Claims may describe novel therapeutic applications. For example, treatment of specific cancers, infectious diseases, or chronic conditions, aligning with patenting strategies to extend exclusivity beyond compound claims.
Claim Dependence and Scope:
The patent likely contains independent claims outlining the core innovation, with dependent claims adding specific features, such as dosage ranges, specific combinations, or manufacturing techniques.
Claim Breadth and Enforceability:
In Chile, patent claims must be clear, concise, and supported by the description. Overly broad claims risk invalidation for lack of novelty or inventive step, whereas narrow claims may limit commercial exclusivity.
Patent Landscape in Chile and the Latin American Context
Chile's patent system is aligned with international standards, including those established by the TRIPS agreement. The country recognizes pharmaceutical patents, balancing innovation incentives with public health interests, especially following law reforms aligned with the patent law [1].
Latin American Patent Environment:
The region exhibits a concentrated patent landscape with major pharmaceutical companies seeking patent protection for innovative drugs, often filing in multiple jurisdictions to secure regional exclusivities.
Notable Patent Trends:
- Focus on biologics and targeted therapies, reflecting global R&D shifts.
- Use of secondary patents covering formulations and methods to extend market rights.
- Challenges include patentability issues concerning evergreening strategies or incremental innovations.
Patent CL2012000952 in Context:
It appears alongside other patents covering similar compounds or therapeutic areas, contributing to a regional patent thicket. Such thickets can influence generic entry, with patent litigations or disputes over scope often occurring.
Implications for Stakeholders
For Innovators:
- Ensuring the completeness of patent claims to cover all potential variants and delivery mechanisms.
- Strategically filing for secondary patents to extend market exclusivity.
For Generics and Competitors:
- Analyzing claim scope to design around patents or challenge validity.
- Monitoring patent landscapes for potential infringement risks.
For Regulators and Policymakers:
- Balancing patent exclusivities with access to medicines.
- Ensuring patent policies support innovation while safeguarding public health.
Conclusion
The Chilean patent CL2012000952 likely embodies a targeted, well-defined innovation in the pharmaceutical domain, with claims encompassing the chemical compound, formulations, and therapeutic uses. Its scope appears tailored to establish market exclusivity, supported by Chile's adherence to international patent standards. The patent landscape positioning suggests active patenting within the region, emphasizing the importance of precise claim drafting and landscape monitoring for both innovator and generic sectors.
Key Takeaways
-
The patent's scope is primarily centered on specific chemical or biological compounds, formulations, and therapeutic methods relevant to Chile’s pharmaceutical market.
-
Strategic claim drafting influences patent strength, enforceability, and market protection.
-
Chile’s patent system offers robust protection aligned with international standards, yet the regional landscape exhibits strategic patenting tactics aimed at extending exclusivity.
-
Stakeholders should conduct precise landscape analysis to avoid infringement and identify opportunities for patent challenges.
-
Monitoring patent life cycles and claim scopes is vital for timely market entry or patent expiry planning.
FAQs
Q1: How broad are the claims of patent CL2012000952?
The claims likely focus on specific chemical entities and formulations, making them moderately broad within the scope of the detailed description but restricted enough to prevent challenge for obviousness.
Q2: Does this patent protect only the chemical compound or also the therapeutic method?
It potentially covers both, if claims encompass the compound's use in particular therapeutic indications, which is common in pharmaceutical patents.
Q3: How can competitors avoid infringing on this patent?
By designing around the claims—either by modifying the chemical structure to fall outside the scope or developing alternative formulations not covered by the patent claims.
Q4: What is the typical duration of patent protection for this type of patent in Chile?
Under Chilean law, pharmaceutical patents are generally granted for 20 years from the filing date, contingent upon appropriate maintenance fees.
Q5: How does this patent influence drug accessibility in Chile?
While it grants exclusivity and incentivizes innovation, it may also delay generic entry, affecting drug prices and access unless alternative pathways, like compulsory licensing, are utilized.
References
[1] Chilean Patent Law Reform and Regulatory Framework, 2010.
